Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1139188

Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia


Mareković, Ivana; Bošnjak, Zrinka; Jurić, Karla; Ćorić, Mario; Popović-Grle, Sanja
Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia // Journal of chemotherapy, 30 (2018), 3; 189-191 doi:10.1080/1120009x.2018.1452585 (međunarodna recenzija, članak, stručni)


CROSBI ID: 1139188 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia
(Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia)

Autori
Mareković, Ivana ; Bošnjak, Zrinka ; Jurić, Karla ; Ćorić, Mario ; Popović-Grle, Sanja

Izvornik
Journal of chemotherapy (1120-009X) 30 (2018), 3; 189-191

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
Escherichia coli ; extended spectrum beta-lactamases ; guidelines ; nitroxoline ; uncomplicated urinary tract infections

Sažetak
Nitroxoline (NTX), 5-nitro-8-hydroxyquinoline is an oral antibiotic with mechanism of bacteriostatic activity that is based on chelation of divalent cations required for bacterial RNA polymerase. Susceptibility to NTX of 100 Escherichia coli urine isolates was determined at the Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb during September and October 2017. Antimicrobial susceptibility was tested by disc diffusion and the results were interpreted according to the European Committee for Antimicrobial Susceptibility Testing (EUCAST) standards. All E. coli isolates, including ESBL-positive ones, were fully susceptible to imipenem, meropenem, amikacin, fosfomycin and NTX. This is the first report from Croatia about sensitivity of E. coli isolates to NTX. Besides fosfomycin, NTX was the only antimicrobial drug available for peroral administration demonstrating the sensitivity for all tested isolates. The results of the study demonstrated the potential of NTX as an additional therapeutically applicable option for the treatment of uncomplicated UTI.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinika za plućne bolesti "Jordanovac",
Klinički bolnički centar Zagreb

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Mareković, Ivana; Bošnjak, Zrinka; Jurić, Karla; Ćorić, Mario; Popović-Grle, Sanja
Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia // Journal of chemotherapy, 30 (2018), 3; 189-191 doi:10.1080/1120009x.2018.1452585 (međunarodna recenzija, članak, stručni)
Mareković, I., Bošnjak, Z., Jurić, K., Ćorić, M. & Popović-Grle, S. (2018) Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia. Journal of chemotherapy, 30 (3), 189-191 doi:10.1080/1120009x.2018.1452585.
@article{article, author = {Marekovi\'{c}, Ivana and Bo\v{s}njak, Zrinka and Juri\'{c}, Karla and \'{C}ori\'{c}, Mario and Popovi\'{c}-Grle, Sanja}, year = {2018}, pages = {189-191}, DOI = {10.1080/1120009x.2018.1452585}, keywords = {Escherichia coli, extended spectrum beta-lactamases, guidelines, nitroxoline, uncomplicated urinary tract infections}, journal = {Journal of chemotherapy}, doi = {10.1080/1120009x.2018.1452585}, volume = {30}, number = {3}, issn = {1120-009X}, title = {Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia}, keyword = {Escherichia coli, extended spectrum beta-lactamases, guidelines, nitroxoline, uncomplicated urinary tract infections} }
@article{article, author = {Marekovi\'{c}, Ivana and Bo\v{s}njak, Zrinka and Juri\'{c}, Karla and \'{C}ori\'{c}, Mario and Popovi\'{c}-Grle, Sanja}, year = {2018}, pages = {189-191}, DOI = {10.1080/1120009x.2018.1452585}, keywords = {Escherichia coli, extended spectrum beta-lactamases, guidelines, nitroxoline, uncomplicated urinary tract infections}, journal = {Journal of chemotherapy}, doi = {10.1080/1120009x.2018.1452585}, volume = {30}, number = {3}, issn = {1120-009X}, title = {Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia}, keyword = {Escherichia coli, extended spectrum beta-lactamases, guidelines, nitroxoline, uncomplicated urinary tract infections} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font